AstraZeneca Annual Report and Form 20-F Information 2008

Cross-reference to Form 20-F

The information in this document that is referenced on this page is included in AstraZeneca’s Form 20-F for 2008 (2008 Form 20-F) and is filed with the Securities and Exchange Commission (SEC). The 2008 Form 20-F is the only document intended to be incorporated by reference into any filings by AstraZeneca under the Securities Act of 1933, as amended. References to major headings include all information under such major headings, including subheadings. References to subheadings include only the information contained under such subheadings. Graphs are not included unless specifically identified. The 2008 Form 20-F has not been approved or disapproved by the SEC, nor has the SEC passed comment upon the accuracy or adequacy of the 2008 Form 20-F. The 2008 Form 20-F filed with the SEC may contain modified information and may be updated from time to time.

3 KEY INFORMATION

A.	Selected financial data
	Financial Highlights
	Directors’ Report – Reporting Our Performance – Financial
	Group Financial Record
	Additional Information – Shareholder Information
D.	Risk Factors
	Risk – Principal Risks and Uncertainties

Back to the top

4 INFORMATION ON THE COMPANY

A.	History and development of the Company
	Additional Information – History and development of the Company
	Financial Review – Investments, divestments and capital expenditure
	Directors’ Report – Supply and Manufacturing
	Note 7 – Property, plant and equipment
	Note 22 – Acquisitions of business operations
B.	Business overview
	Directors’ Report
C.	Organisational structure
	Directors’ Report – Other Company Disclosures and Information
	Principal Subsidiaries
D.	Property, plants and equipment
	Directors’ Report – Our Resources

Back to the top

5 OPERATING AND FINANCIAL REVIEW AND PROSPECTS

A-F.	Directors’ Report
	Financial Review
	Note 16 – Financial instruments

Back to the top

6 DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES

A.	Directors and senior management
	Directors’ Report – Board of Directors at 31 December 2008
B.	Compensation
	Remuneration Report – Directors’ Remuneration Report
	Note 23 – Post-retirement benefits
	Note 27 – Statutory and other information
C.	Board practices
	Directors’ Report – Board of Directors at 31 December 2008
	Remuneration Report – Directors’ Remuneration Report
	Directors’ Report – Operation of the Board of Directors
	Directors’ Report – Operation of Board Committees
D.	Employees
	Note 24 – Employee costs and share option plans for employees
	Directors’ Report – People
E.	Share ownership
	Remuneration Report – Directors’ Interests in Shares
	Note 24 – Employee costs and share option plans for employees

Back to the top

7 MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS

A.	Major shareholders
	Additional Information – Major Shareholdings
B.	Related party transactions
	Additional Information – Related Party Transactions
	Note 27 – Statutory and other information

Back to the top

8 FINANCIAL INFORMATION

A.	Consolidated statements and other financial information
	Financial Statements (excluding Directors’ responsibilities and Auditor’s opinion)
B.	Significant changes
	Note 27 – Statutory and other information

Back to the top

9 THE OFFER AND LISTING

A4.	Price history of listed stock
	Additional Information – Shareholder Information
C.	Markets
	Additional Information – Shareholder Information

Back to the top

10 ADDITIONAL INFORMATION

B.	Memorandum and Articles of Association
	Additional Information – Memorandum and Articles of Association
C.	Material contracts
D.	Exchange controls
	Additional Information – Exchange Controls and other Limitations affecting Security Holders
E.	Taxation
	Financial Review – Taxation
H.	Documents on display
	Additional Information – Documents on Display
I.	Subsidiary information
	Principal Subsidiaries

Back to the top

11 QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Financial Review – Financial Risk Management Policies

Back to the top

15 CONTROLS AND PROCEDURES

Directors’ Report – UK Corporate Governance Requirements

Back to the top

16 [RESERVED]

A.	Audit Committee financial expert
	Directors’ Report – Audit Committee
B.	Code of ethics
	Directors’ Report – Code of Conduct
C.	Principal accountant fees and services
	Note 27 – Statutory and other information
D.	Exemptions from the listing standards for audit committees
E.	Purchases of equity securities by the issuer and affiliated purchasers
	Note 20 – Share capital of parent company
G.	Corporate Governance
	Directors’ Report – Principal UK and US Governance Requirements